Part of Stock market activity was reported to be centered in New York City on June 24, 2026.

How does the class action lawsuit against GRAIL affect Josh Wilson?

Josh Wilson represents investors in class action against GRAIL The class action lawsuit against GRAIL involves allegations of securities fraud related to the company's NHS-Galleri trial. This litigation targets the company and its executives for allegedly making false and misleading statements to investors. Josh Wilson is leading the legal efforts for the investors affected by the decline in GRAIL's stock price.

Reported by 4 independent outlets Written Yesterday

Effect: Mild negative
How direct: 2 steps, all reported
When: Right away
The story: Gone quiet

How it reaches Josh Wilson

Reported by news outlets

The class action lawsuit alleges that GRAIL made false and misleading statements to investors regarding the success of its NHS-Galleri cancer detection trial.

3 reports connect these two. Brind only summarizes; follow a link to read the reporting itself.
- pr-inside.com Jul 3
- gazettextra.com Jul 1
- stockhouse.com Jun 17
Josh Wilson, through his firm, is leading the class action against GRAIL, representing investors who purchased GRAIL stock between May 13, 2025, and February 19, 2026.

1 report connects these two. Brind only summarizes; follow a link to read the reporting itself.
- pr-inside.com Jul 3

Tap any step to see the evidence behind it.

The facts so far

As reported. Each one links to where it comes from.

The class action lawsuit alleges securities fraud against GRAIL regarding the NHS-Galleri trial.gazettextra.com, stockhouse.com
The class period for investors affected by the lawsuit was May 13, 2025, to February 19, 2026.pr-inside.com, prnewswire.com, gazettextra.com, stockhouse.com
The lawsuit seeks to recover losses from the decline in GRAIL's stock price from $101.53 to $50.21 per share.pr-inside.com, gazettextra.com, stockhouse.com

Why it matters

The lawsuit focuses on the integrity of GRAIL's corporate disclosures during a critical period. The allegations center on the company's failure to accurately represent the potential of its cancer detection technology.

This situation places the burden of investor recovery on the successful outcome of the class action. The outcome will determine the potential financial recovery for the investors represented by Josh Wilson.

What we don't know yet

What is the current status of the class action lawsuit?
What is the expected timeline for the class action resolution?

Is this still moving?

Gone quiet

Reports: 18
Developments: 11
Repetition: 39%

What would change this answer

The court rules in favor of the investors' claimsThe class action against GRAIL could result in financial recoveries for investors.

GRAIL releases further information on the trial's shortcomingsThe scope of the allegations against the company may expand.

Who else could feel it

Other paths from the same event.

Robbins Geller Rudman & Dowd LLPReportedRobbins LLP leads class action against Grail over stock losses

Reporting

Keep going

The full eventInvestor Class Action Lawsuit Filed Against GRAIL Over Securities Allegations Everything aboutJosh Wilson

Brind's analysis is written by AI from the reporting linked above and can be wrong. It explains possible effects; it is not investment advice.